The DOI matches its Crossref record.
Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
Abstract
LPS stimulated human blood mononuclear leukocytes to produce a chemotactic factor for human neutrophils. The effect of LPS was dose-dependent; 10 micrograms/ml was optimal for production of chemotactic factor. Chemotactic activity was detected 3 hr after LPS stimulation, and reached its peak at 12 hr. No activity was detected in culture supernatants of unstimulated cells, provided LPS-free media were selected. Isoelectric point of the factor, determined by chromatofocusing, was approximately 8 to 8.5. Molecular weight was approximately 10 kilodaltons by Sephacryl S-200 gel filtration or by HPLC gel filtration on TSK-2000 and -3000 columns in succession. The gel filtration fractions were also assayed for IL 1 activity. The elution position of IL 1 activity corresponded to a m.w. of 18. There was no chemotactic activity in the Il 1 activity peak. Furthermore, highly purified natural IL 1 alpha and -beta and recombinant Il 1 alpha and -beta did not exhibit chemotactic activity for neutrophils in our assay. Among mononuclear leukocytes, the monocyte was the principal producer of neutrophil chemotactic factor. These results suggest that a chemotactic factor for neutrophils, different from IL 1, is produced by LPS-stimulated blood monocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
Sex differences in immune responses that underlie COVID-19 disease outcomes
Takahashi, T., Ellingson, M. K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., Oh, J. E., Tokuyama, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2700-3 · Cited by 1,459
Essential involvement of interleukin-8 (IL-8) in acute inflammation
Harada, A., Sekido, N., Akahoshi, T., Wada, T., Mukaida, N., & Matsushima, K. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.56.5.559 · Cited by 1,041
Self-citationThe Neutrophil-Activating Protein (NAP-1) Is Also Chemotactic for T Lymphocytes
Larsen, C. G., Anderson, A. O., Appella, E., Oppenheim, J. J., & Matsushima, K. (1989) · Science · doi:10.1126/science.2648569 · Cited by 1,038
Self-citationMatsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., & Oppenheim, J. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1883 · Cited by 1,021
Self-citationYoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 982
Self-citationLi Jeon, N., Baskaran, H., Dertinger, S. K. W., Whitesides, G. M., Van De Water, L., & Toner, M. (2002) · Nature Biotechnology · doi:10.1038/nbt712 · Cited by 917
Matsushima, K., Larsen, C. G., DuBois, G. C., & Oppenheim, J. J. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1485 · Cited by 756
Self-citationStandiford, T. J., Kunkel, S. L., Basha, M. A., Chensue, S. W., Lynch, J. P., Toews, G. B., Westwick, J., & Strieter, R. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114928 · Cited by 687
Human monocyte chemoattractant protein-1 (MCP-1)
Leonard, E. J., & Yoshimura, T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90035-8 · Cited by 663
Self-citationThe CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases
Russo, R. C., Garcia, C. C., Teixeira, M. M., & Amaral, F. A. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.894886 · Cited by 647
A novel neutrophil-activating factor produced by human mononuclear phagocytes.
Peveri, P., Walz, A., Dewald, B., & Baggiolini, M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1547 · Cited by 647
Ramesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639
“Chemokines are a group of secreted proteins within the cytokine family whose generic function is to induce cell migration [2, 3].”
BackgroundMukaida, N., Mahe, Y., & Matsushima, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45336-1 · Cited by 636
Self-citationCytokines in chronic obstructive pulmonary disease
Chung, K. F. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00229701 · Cited by 625
Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF
Matsushima, K., & Oppenheim, J. J. (1989) · Cytokine · doi:10.1016/1043-4666(89)91043-0 · Cited by 607
Self-citationWolpe, S. D., Davatelis, G., Sherry, B., Beutler, B., Hesse, D. G., Nguyen, H. T., Moldawer, L. L., Nathan, C. F., Lowry, S. F., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.570 · Cited by 571
Noach, L. A., Bosma, N. B., Jansen, J., Hoek, F. J., Van Deventer, S. J. H., & Tytgat, G. N. J. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409096833 · Cited by 521
Interleukin-8: An evolving chemokine
Matsushima, K., Yang, D., & Oppenheim, J. J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155828 · Cited by 520
Self-citationWalz, A., Peveri, P., Aschauer, H., & Baggiolini, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90432-3 · Cited by 505
Characterization of cytokine-induced hyperalgesia
Watkins, L. R., Wiertelak, E. P., Goehler, L. E., Smith, K. P., Martin, D., & Maier, S. F. (1994) · Brain Research · doi:10.1016/0006-8993(94)91566-0 · Cited by 502
Endothelial Interleukin-8: A Novel Inhibitor of Leukocyte-Endothelial Interactions
Gimbrone, M. A., Obin, M. S., Brock, A. F., Luis, E. A., Hass, P. E., Hébert, C. A., Yip, Y. K., Leung, D. W., Lowe, D. G., Kohr, W. J., et al. (1989) · Science · doi:10.1126/science.2688092 · Cited by 452
Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection
TEOH, N. C., & FARRELL, G. C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03056.x · Cited by 441
Engelhardt, E., Toksoy, A., Goebeler, M., Debus, S., Bröcker, E.-B., & Gillitzer, R. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65699-4 · Cited by 435
Liu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429
Clark-Lewis, I., Schumacher, C., Baggiolini, M., & Moser, B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54472-0 · Cited by 425
Identification and characterization of macrophage inflammatory protein 2.
Wolpe, S. D., Sherry, B., Juers, D., Davatelis, G., Yurt, R. W., & Cerami, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.612 · Cited by 425
Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines
Wolpe, S. D., & Cerami, A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.14.2687068 · Cited by 424
Chemokines and Their Receptors in the Central Nervous System
Bajetto, A., Bonavia, R., Barbero, S., Florio, T., & Schettini, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0214 · Cited by 416
Regulation of Interleukin-8 Gene Expression
Roebuck, K. A. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313866 · Cited by 415
De Larco, J. E., Wuertz, B. R. K., & Furcht, L. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0760 · Cited by 412
Hall, R. I., Smith, M. S., & Rocker, G. (1997) · Anesthesia & Analgesia · doi:10.1097/00000539-199710000-00011 · Cited by 407
Mukaida, N., Harada, A., & Matsushima, K. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00022-1 · Cited by 401
Self-citationThe biologic significance of white blood cells in semen
Wallach, E. E., & Wolff, H. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57588-8 · Cited by 396
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Bringhen, S., Larocca, A., Rossi, D., Cavalli, M., Genuardi, M., Ria, R., Gentili, S., Patriarca, F., Nozzoli, C., Levi, A., et al. (2010) · Blood · doi:10.1182/blood-2010-07-294983 · Cited by 381
CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
Kazanietz, M. G., Durando, M., & Cooke, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00471 · Cited by 356
Cominelli, F., Nast, C. C., Clark, B. D., Schindler, R., Lierena, R., Eysselein, V. E., Thompson, R. C., & Dinarello, C. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114799 · Cited by 333
Bajetto, A., Bonavia, R., Barbero, S., & Schettini, G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01091.x · Cited by 318
Van Damme, J., Van Beeumen, J., Opdenakker, G., & Billiau, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.4.1364 · Cited by 314
Structure-function relationships of antimicrobial peptides
Hwang, P. M., & Vogel, H. J. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-2-3-235 · Cited by 313
Tang, S., Leung, J. C. K., Abe, K., Chan, K. W., Chan, L. Y. Y., Chan, T. M., & Lai, K. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16079 · Cited by 296
Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass
Finn, A., Naik, S., Klein, N., Levinsky, R. J., Strobel, S., & Elliott, M. (1993) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33806-1 · Cited by 285
Brennan, F. M., Zachariae, C. O. C., Chantry, D., Larsen, C. G., Turner, M., Maini, R. N., Matsushima, K., & Feldmann, M. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200938 · Cited by 282
Self-citationCytokine generation in stored platelet concentrates
Stack, G., & Snyder, E. (1994) · Transfusion · doi:10.1046/j.1537-2995.1994.34194098597.x · Cited by 277
Bilusic, M., Heery, C. R., Collins, J. M., Donahue, R. N., Palena, C., Madan, R. A., Karzai, F., Marté, J. L., Strauss, J., Gatti-Mays, M. E., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0706-x · Cited by 274
Regulation of IL-8 and IL-1 expression in Crohn's disease associated NOD2/CARD15 mutations
Li, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh182 · Cited by 271
Positive and Negative Regulation of NF-κB by COX-2
Poligone, B., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106599200 · Cited by 263
Carré, P. C., Mortenson, R. L., King, T. E., Noble, P. W., Sable, C. L., & Riches, D. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115501 · Cited by 253
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury
Whalen, M. J., Carlos, T. M., Kochanek, P. M., Wisniewski, S. R., Bell, M. J., Clark, R. S. B., DeKosky, S. T., Marion, D. W., & Adelson, D. P. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00003 · Cited by 175
Cordaro, M., Cuzzocrea, S., & Crupi, R. (2020) · Antioxidants · doi:10.3390/antiox9030216 · Cited by 98
Wahaidi, V. Y., Kowolik, M. J., Eckert, G. J., & Galli, D. M. (2011) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2011.01710.x · Cited by 32
Metadata
- Authors
- Yoshimura, T., Matsushima, K., Oppenheim, J. J., & Leonard, E. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1987-08-01
- Volume
- 139
- Issue
- 3
- Pages
- 788-793
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1510258932
- Cited by
- 610
- References
- 0
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.